Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
25.6M
-
Shares change
-
-637K
-
Total reported value, excl. options
-
$302M
-
Value change
-
-$15.3M
-
Number of buys
-
23
-
Number of sells
-
-15
-
Price
-
$11.79
Significant Holders of Jade Biosciences, Inc. - COM (AVTE) as of Q4 2021
52 filings reported holding AVTE - Jade Biosciences, Inc. - COM as of Q4 2021.
Jade Biosciences, Inc. - COM (AVTE) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.6M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (8.26M shares), Sofinnova Investments, Inc. (3.76M shares), Atlas Venture Life Science Advisors, LLC (3.1M shares), BAKER BROS. ADVISORS LP (1.83M shares), Cormorant Asset Management, LP (1.83M shares), CITADEL ADVISORS LLC (1.6M shares), TCG Crossover Management, LLC (853K shares), BlackRock Inc. (730K shares), FMR LLC (718K shares), and OUP Management Co., LLC (604K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.